Latigo Bio

Thousand Oaks, CA · Founded 2018 · Privately Held (backing)

Operator of a biotechnology company intended to develop novel and non-opioid therapies for chronic pain. Latigo Bio is based in Thousand Oaks, CA and was founded in 2018. Its last reported valuation was $530 million in Mar 2025. It has raised $304 million.

Last reported valuation

$530.0M

Oct 2026

Priced at

—

Total raised

$304.0M

Last round

—

How much has Latigo Bio raised?

$304.0Macross 0 recorded rounds

Free account

More of Latigo Bio with a free account

·The complete investor list: 14 names
·Watch Latigo Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Latigo Bio investors

14 investors are on record for Latigo Bio, including Alexandria Venture Investments, Qatar Investment Authority, Blue Owl Capital and Foresite Capital. By type, the record holds 4 venture capital firms, 1 hedge fund and 1 asset manager.

For fundraisers

Raising for a company like Latigo Bio?

14 investors have backed Latigo Bio.

See all 14 investors →

Frequently asked about Latigo Bio

How much has Latigo Bio raised?: Latigo Bio has raised $304.0M in total across 0 recorded funding rounds.